The production of oxygen free radicals (OFR) by leucocytes was evaluated ex vivo by chemiluminescence (CL) before, during and after routine coronary artery bypass surgery (group A, n=11). The possibility of leucocyte trapping in the coronary circulation during the early reperfusion period was also investigated (group B, n=9). In group A, arterial blood samples were taken immediately before the start of surgery during anaesthesia, five minutes before and five and 30 minutes after the start of cardiopulmonary bypass (CPB), five minutes before and five and 30 minutes after the start of reperfusion of the heart, and then four and 24 hours after the end of CPB. In group B, arterial and coronary sinus blood samples were simultaneously drawn five and 30 minutes after the release of the aortic crossclamp. All blood samples were corrected for haemodilution. In group A, both CL and the level of circulating leucocytes declined during CPB. The lowest value of CL was measured 30 minutes after the start of CPB (69± 2% of baseline values) (mean±SEM). The lowest level of leucocytes was found after 30 minutes of CPB: 2.6±0.4 (109/l) vs 4.2±0.5 before surgery. Twenty-four hours after CPB, CL was increased to 170±49% and a leucocytosis was present (12.2±1.1). In group B, after five minutes of reperfusion the number of circulating leucocytes in arterial blood was 3.8±0.9 x 10 9/l as compared to 2.2±0.5 x 109/l in the coronary sinus (p<0.0017). However, no such difference was found after 30 minutes of reperfusion. The decreased CL during CPB was probably due to in vivo activation and exhaustion of leucocytes. The postischaemic trapping of these cells may play a pathogenetic role in reperfusion injury.
Get full access to this article
View all access options for this article.
References
1.
Feijen J.Thrombogenesis caused by blood-foreign surface interaction. In: Kenedi RM et al. eds, Artificial organs. Baltimore: University Press, 1977 : 235-47.
2.
Gerbode Fla.A surgeon's view of extracorporeal circulation. Ann Surg1985; 201: 263-67.
3.
Chenoweth DE, Cooper SW, Hugle TE, Stewart RW, Blackstone EH, Kirklin JWComplement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins. N Engl J Med1981; 304: 497-503.
4.
Kirklin JK, Westaby S., Blackstone EH, Kirklin JW, Chenoweth DE, Pacifico ADComplement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg1983; 86: 845-56.
5.
Jacob HSComplement mediated leucoembolization. A mechanism of tissue damage during extracorporeal perfusion, myocardial infarction and in shock; a review. Q J Med1983; 52: 289-96.
Simpson PJ, Lucchesi BRFree radicals and myocardial ischaemia and reperfusion injury. J Lab Clin Med1987; 110 : 13-30.
8.
Cavarocchi NC , England MD, Schaff HV et al. Oxygen free radical generation during cardiopulmonary bypass: correlation with complement activation . Circulation1986; 74(supp III): 111-30.
9.
Cavarocchi NC , England MD, O'Brien JF et al. Superoxide generation during cardiopulmonary bypass: is there a role for Vitamin E?J Surg Res1986; 40 : 519-27.
10.
Royston D., Flemming JS, Desai JB, Westaby S., Taylor KMIncreased production of peroxidation products with cardiac operations. Evidence of free radical generation. J Thorac Cardiovasc Surg1986; 91: 759-65.
Schmid-Schönbein G., Engler RLGranulocytes as active participants in acute myocardial ischemia and infarction. Am J Cardiovasc Pathol1986; 1: 15-30.
13.
Semb AG, Ytrehus K., Vaage J., Myklebust R., Mjös ODFunctional impairment in isolated rat hearts induced by activated granulocytes: protective effect of oxygen free radical scavengers. J Mol Cell Cardiol1989; 21: 877-87.
14.
Breda MA, Drinkwater DC, Laks H. et al . Prevention of reperfusion injury in the neonatal heart with leukocyte-depleted blood. J Thorac Cardiovasc Surg1989; 97: 654-65.
15.
Allen EC, Loose LDPhagocytic activation of a luminol-dependent chemiluminescence in rabbit alveolar and peritoneal macrophages. Biochem Biophys Res Commun1976; 69: 245-52.
16.
Winer BJStatistical principles in experimental design. New York: MacGraw-Hill Book Company, 1977: 515-45.
17.
Nguyen R., Golub R., Feuillet-Fieux MN, Descamps-Latscha B. Modulation of human granulocyte and monocyte chemiluminescence response: evidence for distinct free radical generation systems. J Clin Lab Immunol1983; 12: 47-55.
18.
Rosen H., Klebanoff SJChemiluminescence and superoxide production by myeloperoxidase-deficient leukocytes. J Clin Invest1976; 58: 50-60.
19.
Mills EL, Quie PGChemiluminescence response of phagocytosing neutrophils from male and female patients with chronic granulomatous disease and their carier relatives (Abstr) . 8th Ann Meeting Am Soc Photobiol, Workshop on Biological Chemiluminescence, 1980: 149.
20.
De Chatelet L., Long G., Shirley P. et al. Mechanism of the lumanol-dependent chemiluminescence of human neutrophils. J Immunol1982; 129: 1589-93.
21.
Davies J., Sheppard K., Fletcher Jr.The effects of surgery on the activity of neutrophil granule proteins. Br J Haematol1983; 53 : 5-13.
22.
Wilson JWThe pulmonary cellular and subcellular alterations of extracorporeal circulation . Surg Clin N Am1974; 54: 1203-21.
23.
Lanser ME, Brown GE, Mora R., Coleman W., Sigel JHTrauma serum suppress superoxide production by normal neutrophils. Arch Surg1986a; 121: 157-62.
24.
Lanser ME, Mao P., Brown G., Coleman W., Siegel JHSerum-mediated depression of neutrophil chemiluminescence following blunt trauma. Ann Surg1985; 202: 111-18.
25.
Lanser ME, Mao P., Brown GE, Mora R., Siegel JMNeutrophil chemiluminescence and opsonic fibronectin levels following blunt trauma. J Surg Res1986b; 41: 264-73.
26.
Regel G., Nerlich ML, Dwenger A., Seideel J., Schmidt C., Sturm JAFunction of neutrophils and the RES in endotoxemia. J Surg Res1986; 42 : 74-84.
Salo M., Pertilä J., Lethonen OPGranulocyte chemiluminescence in patients with postoperative infections . Arch Surg1988; 123: 17-22.
29.
Dwenger A., Regel G., Schweiter G.Bronchoalveolar lavage fluid and plasma proteins, chemiluminescence response and protein contents of polymorphonuclear leukocytes from blood and BAL in traumatized patients. J Clin Chem Clin Biochem1986; 24: 73-88.
30.
Weismann G. , Smolen JE, Korchak HMRelease of inflammatory mediators from stimulated neutrophils. N Engl J Med1980; 303: 27-34.
31.
Kloner RA, Ganote CE, Jennings RBThe 'no-reflow' phenomenon after temporary coronary occlusion in the dog . J Clin Invest1974; 54: 1496-1508.
32.
Schofer J., Montz R., Mathey D.Scintigraphic evidence of the 'no-reflow' phenomenon in human beings after coronary thrombolysis. J Am Coll Cardiol1985; 5: 593-98.
33.
Chatelain P. , Latour JG, Tran D., de Longeril M., Dupras G., Bourassa M.Neutrophil accumulation in experimental myocardial infarcts: relation with extent of injury and effect of reperfusion. Circulation1987; 75: 1083-90.
34.
Semb AG, Vaage J., Mjøs ODOxygen free radical producing leukocytes cause functional depression of isolated rat hearts: role of leukotrienes. J Mol Cell Cardiol1990: in press.
35.
Hartmann JR , Robinson JA, Gunnar RMChemotactic activity in the coronary sinus after experimental myocardial infarction: effects of pharmacologic interventions on ischemic injury. Am J Cardiol1977 ; 40: 550-55.
36.
Pinckard RN , O'Rourke RA, Crawford MH et al. Complement localization and mediation of ischemic injury in baboon myocardium. J Clin Invest1980: 1050-56.
37.
Rossen RD, Swain JL, Michael LH, Weakly S., Giannini E., Entmann MLSelective accumulation of the first component of complement and leukocytes in ischemic canine heart muscle. A possible initiator of an extra myocardial mechanism of injury. Circ Res1985 ; 57: 119-30.
38.
Scäfer H., Mathey D., Hugo F., Bhakdi S.Deposition of the terminal C5b-9 complement complex in infarcted areas of human myocardium. J Immunol1986;137: 1945-49.
39.
Vaage J., Semb AG, Lie M., Sørlie D.Intracardiac trapping of complement split products (C3a des Arg) after release of the aortic cross-clamp in open heart surgery (Abstr)Proc Scand Soc Thorac Cardiovasc Surg1987: 70.
